Research ArticleOriginal Research
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman and Karen Gunning
The Journal of the American Board of Family
Medicine January 2018, 31 (1) 105-112; DOI: https://doi.org/10.3122/jabfm.2018.01.170210
Nicholas Cox
the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
Casey R. Tak
the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
Susan E. Cochella
the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
Eric Leishman
the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
Karen Gunning
the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).

References
- 1.↵
- 2.↵Centers for Disease Control and Prevention. Understanding the epidemic. Available from: http://www.cdc.gov/drugoverdose/epidemic/index.html. Last updated and reviewed August 20, 2017. Accessed July 29, 2016.
- 3.↵Centers for Disease Control and Prevention. Opioid overdose. Available from: http://www.cdc.gov/drugoverdose/index.html. Last updated and reviewed October 23, 2017. Accessed July 29, 2016.
- 4.↵Library of Congress. S.524 - Comprehensive Addiction and Recovery Act of 2016, Pub. L. No. 114–198, 114th Congress. Available from: https://www.congress.gov/bill/114th-congress/senate-bill/524/text. Published July 22, 2016. Accessed July 22, 2016.
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Leverence RR,
- Williams RL,
- Potter M,
- et al
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Clark JD
- 13.↵
- Elder NC,
- Simmons T,
- Regan S,
- Gerrety E
- 14.↵
- 15.↵
- DiPaula BA,
- Menachery E
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Doherty RB,
- Crowley RA
- 21.↵
- Giberson S,
- Yoder S,
- Lee MP
- 22.↵
- Valgus J,
- Jarr S,
- Schwartz R,
- Rice M,
- Bernard SA
- 23.↵
- 24.↵
- Thompson CA
- 25.↵
- Elder N,
- Penm M,
- Pallerla H,
- et al
In this issue
The Journal of the American Board of Family
Medicine
Vol. 31, Issue 1
January-February 2018
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman, Karen Gunning
The Journal of the American Board of Family
Medicine Jan 2018, 31 (1) 105-112; DOI: 10.3122/jabfm.2018.01.170210
Jump to section
Related Articles
- No related articles found.